The Cohort Study of Uveitis Patients
ConditionUveitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
About this trial
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The diagnosis is uveitis; The agreement of enrolling this study;
Disqualifiers
Uveitis during the first month after any intraocular surgery; <18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.
Trial population
The study population are adult uveitis patients.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
600 Participants
are grouped into 2 trial groupsGroup A: Noninfectious uveitis
Group B: Infectious uveitis
Trial outcomes
Primary outcomes
1
The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
Time frame
12 months post-treatment2
The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
Time frame
12 months post-treatmentSecondary outcomes
1
Best corrected visual acuity
Best corrected visual acuity
Time frame
1 month post-treatment2
Best corrected visual acuity
Best corrected visual acuity
Time frame
3 months post-treatment3
Best corrected visual acuity
Best corrected visual acuity
Time frame
6 months post-treatment4
Best corrected visual acuity
Best corrected visual acuity
Time frame
12 months post-treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov